Japanese Drug Could Regrow Teeth by 2030

Imagine regrowing a lost tooth the way a child grows their adult teeth. That dream is moving closer to reality in Japan, where scientists are advancing a treatment that could change dentistry forever.

Toregem Biopharma has secured $5.3 million in new funding to accelerate clinical trials of a drug that triggers natural tooth growth in humans. The company successfully tested the approach in mice and completed an initial safety trial with adult men last year.

The treatment works by blocking a protein called USAG-1, which naturally suppresses tooth growth in humans. By neutralizing this protein with an antibody, researchers believe they can wake up dormant tooth buds and trigger new teeth to grow from a person's own tissue.

The company demonstrated the concept in 2021 when they restored teeth in mice born without them due to genetic deficiencies. A 2024 study suggested the same approach could work in humans, setting the stage for expanded trials now underway in Japan.

Toregem aims to bring the treatment to market by 2030. That would offer millions of people an alternative to dentures and implants, which can't match the function and feel of natural teeth.

The science does face some hurdles. Dental experts note that adults have fewer of the specialized cells needed for tooth development compared to children, which could limit who benefits from the treatment. Researchers also need to figure out how to target specific teeth without triggering unwanted growth elsewhere in the mouth.

The Bright Side

Even with these challenges, the progress represents a seismic shift in how we think about dental care. For decades, losing a tooth meant accepting an artificial replacement. This research suggests we might soon activate the body's natural ability to replace what's been lost.

The implications reach beyond cosmetics. Natural teeth maintain jaw bone density better than implants and allow people to eat, speak, and smile with confidence. For children born with genetic conditions that prevent tooth development, this could be life changing.

The company's president, Honoka Kiso, captured the vision simply: offering people a way to grow teeth from their own tissues through advanced science. That's not just innovative dentistry. That's regenerative medicine arriving in your local dental office.

If the next phase of trials succeeds, the 2030s might mark the decade when we stopped accepting tooth loss as permanent.